A novel rabies vaccine based-on toll-like receptor 3 (TLR3) agonist PIKA adjuvant exhibiting excellent safety and efficacy in animal studies

Virology
Yi ZhangLietao Li

Abstract

Vaccination alone is not sufficiently effective to protect human from post-exposure rabies virus infection due to delayed generation of rabies virus neutralizing antibodies and weak cellular immunity. Therefore, it is vital to develop safer and more efficacious vaccine against rabies. PIKA, a stabilized chemical analog of double-stranded RNA that interacts with TLR3, was employed as adjuvant of rabies vaccine. The efficacy and safety of PIKA rabies vaccine were evaluated. The results showed that PIKA rabies vaccine enhanced both humoral and cellular immunity. After viral challenge, PIKA rabies vaccine protected 70-80% of animals, while the survival rate of non-adjuvant vaccine group (control) was 20-30%. According to the results of toxicity tests, PIKA and PIKA rabies vaccine are shown to be well tolerated in mice. Thus, this study indicates that PIKA rabies vaccine is an effective and safe vaccine which has the potential to develop next-generation rabies vaccine and encourage the start of clinical studies.

References

Jun 1, 1994·Clinical Immunology and Immunopathology·O ThraenhartB Dietzschold
Jan 18, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Henry WildeVisith Sitprija
Jul 30, 2002·The Lancet Infectious Diseases·Charles E RupprechtThiravat Hemachudha
Mar 25, 2011·Environmental Health and Preventive Medicine·Yu-e SongCai-yan Cui
Jul 16, 2013·Current Opinion in Virology·Suzanne P M WeltenRamon Arens
May 23, 2014·Annals of the New York Academy of Sciences·Jing Wang, Hisashi Arase
Jul 22, 2014·Trends in Immunology·Nicole L La Gruta, Stephen J Turner
Aug 16, 2014·Journal of Immunology Research·Anabelle VisperasBooki Min

❮ Previous
Next ❯

Citations

Mar 31, 2018·Human Vaccines & Immunotherapeutics·Zhuofan LiGuoyang Liao
Sep 27, 2018·International Journal of Veterinary Science and Medicine·A El-Sayed
Jun 23, 2019·Vaccines·Hildegund C J Ertl
Jul 6, 2021·Clinical and Experimental Vaccine Research·Iman Ibrahim NegmAly Fahmy Mohamed

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Related Papers

Bulletin de l'Académie nationale de médecine
P Goret, J Benet
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
A GacouinR Thomas
British Medical Journal
Tizzoni, E Centanni
© 2022 Meta ULC. All rights reserved